Buchumschlag

Rectal cancer: state of the art in 2012

Purpose of review To discuss the recent developments of multimodal treatment for patients with local advanced rectal cancer, including incorporation of new chemotherapeutic and targeted agents, and the optimal sequence and timing of treatment components. Recent findings Five randomized trials have b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rödel, Claus (VerfasserIn) , Hofheinz, Ralf-Dieter (VerfasserIn) , Liersch, Torsten (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: July 2012
In: Current opinion in oncology
Year: 2012, Jahrgang: 24, Heft: 4, Pages: 441-447
ISSN:1531-703X
DOI:10.1097/CCO.0b013e328352ea02
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1097/CCO.0b013e328352ea02
Verlag, Volltext: https://journals.lww.com/co-oncology/fulltext/2012/07000/Rectal_cancer___state_of_the_art_in_2012.17.aspx
Volltext
Verfasserangaben:Claus Rödel, Ralf Hofheinz, Torsten Liersch

MARC

LEADER 00000caa a2200000 c 4500
001 1577867998
003 DE-627
005 20240316100458.0
007 cr uuu---uuuuu
008 180724s2012 xx |||||o 00| ||eng c
024 7 |a 10.1097/CCO.0b013e328352ea02  |2 doi 
035 |a (DE-627)1577867998 
035 |a (DE-576)507867998 
035 |a (DE-599)BSZ507867998 
035 |a (OCoLC)1341014305 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rödel, Claus  |d 1966-  |e VerfasserIn  |0 (DE-588)1152978330  |0 (DE-627)101434705X  |0 (DE-576)499988248  |4 aut 
245 1 0 |a Rectal cancer  |b state of the art in 2012  |c Claus Rödel, Ralf Hofheinz, Torsten Liersch 
264 1 |c July 2012 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 24.07.2018 
520 |a Purpose of review To discuss the recent developments of multimodal treatment for patients with local advanced rectal cancer, including incorporation of new chemotherapeutic and targeted agents, and the optimal sequence and timing of treatment components. Recent findings Five randomized trials have been completed to determine whether the addition of oxaliplatin to preoperative, fluorouracil-based chemoradiotherapy (CRT) offers an advantage compared to single-agent fluorouracil CRT. Early results from the ACCORD 12, STAR-01, and NSAPB R-04 trials did not confirm a significant improvement of early efficacy endpoints with the addition of oxaliplatin, whereas the German CAO/ARO/AIO-04 did. Most of the phase II trials incorporating cetuximab into CRT reported disappointingly low rates of pathologic complete response (pCR); the combination of CRT with VEGF inhibition showed encouraging pCR rates; however, it was associated with increased surgical complications. Novel clinical trials address the role of induction chemotherapy, of delayed, minimal or omitted surgery following CRT, or the omission of radiotherapy for selected patients. Summary At this time, the use of oxaliplatin or targeted agents as component of multimodality treatment for rectal cancer outside of a clinical trial is not recommended. The inclusion of different treatment options, according to tumor stage, location, imaging features, and response, will render the multimodal treatment approach of rectal cancer more risk-adapted. 
700 1 |a Hofheinz, Ralf-Dieter  |d 1969-  |e VerfasserIn  |0 (DE-588)121917517  |0 (DE-627)08161876X  |0 (DE-576)292991568  |4 aut 
700 1 |a Liersch, Torsten  |d 1962-  |e VerfasserIn  |0 (DE-588)123818613  |0 (DE-627)706437292  |0 (DE-576)293892725  |4 aut 
773 0 8 |i Enthalten in  |t Current opinion in oncology  |d Philadelphia, Pa. : Lippincott Williams & Wilkins, 1989  |g 24(2012), 4, Seite 441-447  |h Online-Ressource  |w (DE-627)324455887  |w (DE-600)2026986-9  |w (DE-576)093981147  |x 1531-703X  |7 nnas  |a Rectal cancer state of the art in 2012 
773 1 8 |g volume:24  |g year:2012  |g number:4  |g pages:441-447  |g extent:7  |a Rectal cancer state of the art in 2012 
856 4 0 |u http://dx.doi.org/10.1097/CCO.0b013e328352ea02  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://journals.lww.com/co-oncology/fulltext/2012/07000/Rectal_cancer___state_of_the_art_in_2012.17.aspx  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180724 
993 |a Article 
994 |a 2012 
998 |g 121917517  |a Hofheinz, Ralf-Dieter  |m 121917517:Hofheinz, Ralf-Dieter  |d 60000  |d 61200  |e 60000PH121917517  |e 61200PH121917517  |k 0/60000/  |k 1/60000/61200/  |p 2 
999 |a KXP-PPN1577867998  |e 3019399211 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"family":"Rödel","display":"Rödel, Claus","given":"Claus","role":"aut"},{"display":"Hofheinz, Ralf-Dieter","given":"Ralf-Dieter","role":"aut","family":"Hofheinz"},{"display":"Liersch, Torsten","given":"Torsten","role":"aut","family":"Liersch"}],"name":{"displayForm":["Claus Rödel, Ralf Hofheinz, Torsten Liersch"]},"note":["Gesehen am 24.07.2018"],"relHost":[{"pubHistory":["1.1989 -"],"part":{"issue":"4","pages":"441-447","extent":"7","volume":"24","year":"2012","text":"24(2012), 4, Seite 441-447"},"language":["eng"],"title":[{"title_sort":"Current opinion in oncology","title":"Current opinion in oncology"}],"note":["Gesehen am 27.01.2025"],"disp":"Rectal cancer state of the art in 2012Current opinion in oncology","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["324455887"],"zdb":["2026986-9"],"issn":["1531-703X"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"1989","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedDisp":"1989-","publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]"}],"recId":"324455887"}],"physDesc":[{"extent":"7 S."}],"id":{"doi":["10.1097/CCO.0b013e328352ea02"],"eki":["1577867998"]},"origin":[{"dateIssuedDisp":"July 2012","dateIssuedKey":"2012"}],"recId":"1577867998","type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title_sort":"Rectal cancer","subtitle":"state of the art in 2012","title":"Rectal cancer"}]} 
SRT |a ROEDELCLAURECTALCANC2012 

Ähnliche Einträge